We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
(-0.48%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$81.6M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$68M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$61.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$55.5M |
| 5 |
Keurig Dr Pepper
KDP
|
+$44.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$105M |
| 2 |
Organon & Co
OGN
|
+$75.3M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$69M |
| 4 |
Biogen
BIIB
|
+$57.7M |
| 5 |
Central Garden & Pet Co Class A
CENTA
|
+$53.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.29% |
| 2 | Consumer Staples | 5.94% |
| 3 | Technology | 4.58% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Communication Services | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Interparfums
IPAR
$3.95B
| – | – |
-1,874
| Closed | -$267K |
|
252
JPMorgan Chase
JPM
$955B
| – | – |
-84,000
| Closed | -$10.9M |
|
253
CarMax
KMX
$8.04B
| – | – |
-5,742
| Closed | -$369K |
|
254
Kontoor Brands
KTB
$4.62B
| – | – |
-10,425
| Closed | -$504K |
|
255
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
| – | – |
-125,000
| Closed | -$30.3M |
|
256
Momentus
MNTS
$79.9M
| – | – |
-475
| Closed | -$3.47M |
|
|
SDEV
257
Stablecoin Development Corp
SDEV
$52M
| – | – |
-806
| Closed | -$240K |
|
258
ServiceNow
NOW
$121B
| – | – |
-2,820
| Closed | -$262K |
|
|
259
Organon & Co
OGN
$3.56B
| – | – |
-3,200,000
| Closed | -$75.3M |
|
|
OTLY
260
Oatly Group
OTLY
$445M
| – | – |
-75,000
| Closed | -$3.63M |
|
261
Children's Place
PLCE
$58M
| – | – |
-40,000
| Closed | -$1.61M |
|
262
Papa John's
PZZA
$979M
| – | – |
-6,464
| Closed | -$484K |
|
|
RDHL
263
Redhill Biopharma
RDHL
$4.07M
| – | – |
-10,400
| Closed | -$1.06M |
|
264
Rekor Systems
REKR
$88.2M
| – | – |
-6,015,147
| Closed | -$7.52M |
|
265
RH
RH
$3.7B
| – | – |
-17,215
| Closed | -$4.19M |
|
266
Arcadia Biosciences
RKDA
$1.53M
| – | – |
-82,500
| Closed | -$616K |
|
267
RingCentral
RNG
$5.16B
| – | – |
-10,476
| Closed | -$321K |
|
268
RenovoRx
RNXT
$47.8M
| – | – |
-982,921
| Closed | -$3.43M |
|
269
Virax Biolabs
VRAX
$2.32M
| – | – |
-6,000
| Closed | -$1.04M |
|
270
Verastem
VSTM
$516M
| – | – |
-166,667
| Closed | -$830K |
|
271
Energous
WATT
$98.4M
| – | – |
-13,100
| Closed | -$4.24M |
|
272
Walmart Inc
WMT
$894B
| – | – |
-7,722
| Closed | -$380K |
|
273
Petco
WOOF
$834M
| – | – |
-26,515
| Closed | -$239K |
|
274
Williams-Sonoma
WSM
$29.2B
| – | – |
-5,926
| Closed | -$360K |
|
|
GRDX
275
GridAI Technologies Corp
GRDX
$19.5M
| – | – |
-1,498
| Closed | -$241K |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.
- Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
- Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
- Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
- Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
- Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
- Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
- Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.
Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.